These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2655453)

  • 1. Cardiovascular benefits of estrogen replacement therapy.
    Ross RK; Paganini-Hill A; Mack TM; Henderson BE
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1301-6. PubMed ID: 2655453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone-replacement therapy. Weighing the benefits and risks.
    Harv Health Lett; 1997 Oct; 22(12):1-3. PubMed ID: 9674386
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefits and risks of estrogen replacement therapy.
    Lobo RA
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 2):982-9. PubMed ID: 7573295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncontraceptive estrogen use and cardiovascular disease.
    Bush TL; Barrett-Connor E
    Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefits and risks of hormone replacement therapy: an epidemiologic overview.
    Harlap S
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1986-92. PubMed ID: 1605289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy: the need for reconsideration.
    Rosenberg L
    Am J Public Health; 1993 Dec; 83(12):1670-3. PubMed ID: 8259791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women.
    Schwartz J; Freeman R; Frishman W
    J Clin Pharmacol; 1995 Jan; 35(1):1-16. PubMed ID: 7751408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women.
    Schwartz J; Freeman R; Frishman W
    J Clin Pharmacol; 1995 Mar; 35(3):314-29. PubMed ID: 7608324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen therapy of perimenopausal and postmenopausal patients.
    Magera BE; Amerson AB; Wilson E
    Am J Hosp Pharm; 1979 Aug; 36(8):1062-71. PubMed ID: 384786
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
    Roy JA; Sawka CA; Pritchard KI
    J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen use and postmenopausal women: a basis for informed decisions. NIH Consensus Development.
    Gastel B; Cornoni-Huntley J; Brody JA
    J Fam Pract; 1980 Nov; 11(6):851-60. PubMed ID: 7005387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal estrogen, cancer and other considerations.
    Barrett-Connor E
    Women Health; 1986; 11(3-4):179-95. PubMed ID: 3564498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The menopause: benefits and risks of hormone replacement therapy.
    Gambrell RD
    Compr Ther; 1994; 20(10):580-5. PubMed ID: 7859441
    [No Abstract]   [Full Text] [Related]  

  • 17. [Association of estrogens and selective estrogens receptors modulators: towards a renewal of the hormonal treatment?].
    Valéra MC; Chantalat E; Vinel A; Benoit T; Guillaume M; Game X; Gourdy P; Trémollières F; Payrastre B; Arnal JF
    Presse Med; 2015; 44(7-8):805-11. PubMed ID: 26278157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones].
    Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL
    Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen replacement therapy.
    Judd HL; Cleary RE; Creasman WT; Figge DC; Kase N; Rosenwaks Z; Tagatz GE
    Obstet Gynecol; 1981 Sep; 58(3):267-75. PubMed ID: 7022279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.